Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SRDX
|
Joseph J. Stich
SVP of HR, President IVD |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 4.71% |
$112,500
$45.0 p/Share
|
Jan 05
2021 |
|
BAND
|
David A. Morken
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 52,446 Reduced 98.45% |
$8,231,925
$156.96 p/Share
|
Jan 05
2021 |
|
SIBN
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Indirect | 40,000 Reduced 13.75% |
$1,156,800
$28.92 p/Share
|
Jan 05
2021 |
|
ABML
|
Douglas Cole
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.12% |
$19,200
$0.96 p/Share
|
Jan 05
2021 |
|
ABML
|
Douglas Charles Maclellan
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.2% |
$19,200
$0.96 p/Share
|
Jan 05
2021 |
|
AMRK
|
Thor Gjerdrum
President |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 100.0% |
$537,800
$26.89 p/Share
|
Jan 05
2021 |
|
EVER
|
John Brandon Wagner
CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 7,125 Reduced 3.33% |
$262,984
$36.91 p/Share
|
Jan 05
2021 |
|
KVHI
|
Robert J Balog
COO |
SELL
Open market or private sale
|
Direct | 3,159 Reduced 3.2% |
$37,845
$11.98 p/Share
|
Jan 05
2021 |
|
FIXX
|
Albert Seymour |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 6.49% |
$114,400
$11.44 p/Share
|
Jan 05
2021 |
|
TYME
|
Steve Hoffman
Director |
SELL
Open market or private sale
|
Direct | 56,250 Reduced 0.22% |
$76,500
$1.36 p/Share
|
Jan 05
2021 |
|
MXC
|
Tammy Mccomic
PRESIDENT |
SELL
Open market or private sale
|
Direct | 16,500 Reduced 20.57% |
$156,750
$9.5 p/Share
|
Jan 05
2021 |
|
MXC
|
Michael J Banschbach
Director |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 28.57% |
$31,000
$7.75 p/Share
|
Jan 05
2021 |
|
CGRN
|
Frederick S. Hencken Iii
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,569 Reduced 5.23% |
$27,463
$10.69 p/Share
|
Jan 05
2021 |
|
ENOV
|
Matthew L. Trerotola
CEO |
SELL
Open market or private sale
|
Direct | 22,039 Reduced 9.88% |
$844,094
$38.3 p/Share
|
Jan 05
2021 |
|
EPAY
|
Nigel K Savory
Managing Director Europe |
BUY
Open market or private sale
|
Direct | 1,435 Added 1.03% |
$73,572
$51.27 p/Share
|
Jan 05
2021 |
|
EPAY
|
John Francis Kelly
GM, Legal Solutions |
BUY
Open market or private sale
|
Direct | 375 Added 0.65% |
$19,226
$51.27 p/Share
|
Jan 05
2021 |
|
EPAY
|
Norman J Deluca
MD of Banking Solutions |
BUY
Open market or private sale
|
Direct | 700 Added 0.84% |
$35,889
$51.27 p/Share
|
Jan 05
2021 |
|
EPAY
|
Richard Douglas Booth
Chief Financial Officer |
BUY
Open market or private sale
|
Direct | 856 Added 0.82% |
$43,887
$51.27 p/Share
|
Jan 05
2021 |
|
EPAY
|
Robert A Eberle
President & CEO |
BUY
Open market or private sale
|
Direct | 1,743 Added 0.43% |
$89,364
$51.27 p/Share
|
Jan 05
2021 |
|
FLXN
|
Adam Muzikant
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 4,005 Reduced 5.17% |
$44,576
$11.13 p/Share
|
Jan 05
2021 |
|
FLXN
|
Scott Kelley
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 6,829 Reduced 5.67% |
$76,007
$11.13 p/Share
|
Jan 05
2021 |
|
FLXN
|
Kerry Wentworth
Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct | 6,829 Reduced 5.66% |
$76,007
$11.13 p/Share
|
Jan 05
2021 |
|
FLXN
|
Christina Willwerth
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 6,602 Reduced 5.42% |
$73,480
$11.13 p/Share
|
Jan 05
2021 |
|
FLXN
|
Mark S. Levine
General Counsel |
SELL
Open market or private sale
|
Direct | 6,829 Reduced 5.98% |
$76,007
$11.13 p/Share
|
Jan 05
2021 |
|
FLXN
|
David Arkowitz
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 6,073 Reduced 3.87% |
$67,592
$11.13 p/Share
|
Jan 05
2021 |
|
BLFS
|
Walter Villiger
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 18,948 Reduced 0.51% |
$806,048
$42.54 p/Share
|
Jan 05
2021 |
|
BLUE
|
Nick Leschly |
SELL
Open market or private sale
|
Direct | 333 Reduced 0.34% |
$14,968
$44.95 p/Share
|
Jan 05
2021 |
|
BLUE
|
Alison Cecily Finger
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 40 Reduced 0.15% |
$1,798
$44.95 p/Share
|
Jan 05
2021 |
|
BLUE
|
David Davidson
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 48 Reduced 0.12% |
$2,158
$44.95 p/Share
|
Jan 05
2021 |
|
BLUE
|
Jason Cole
Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct | 43 Reduced 0.12% |
$1,933
$44.95 p/Share
|
Jan 05
2021 |
|
BLUE
|
Joanne Smith Farrell
COO, Oncology |
SELL
Open market or private sale
|
Direct | 42 Reduced 0.19% |
$1,888
$44.95 p/Share
|
Jan 05
2021 |
|
BLUE
|
Philip D Gregory
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 45 Reduced 0.13% |
$2,023
$44.95 p/Share
|
Jan 05
2021 |
|
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 19,000 Reduced 0.04% |
$4,370
$0.23 p/Share
|
Jan 05
2021 |
|
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 117,000 Reduced 0.24% |
$30,420
$0.26 p/Share
|
Jan 05
2021 |
|
HHC
|
James Carman
President, Houston Region |
SELL
Open market or private sale
|
Direct | 192 Reduced 7.7% |
$15,012
$78.19 p/Share
|
Jan 05
2021 |
|
IDRA
|
Bryant David Lim
SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct | 1,465 Reduced 3.55% |
$5,728
$3.91 p/Share
|
Jan 05
2021 |
|
IDRA
|
Vincent Milano |
SELL
Open market or private sale
|
Direct | 2,740 Reduced 1.28% |
$10,713
$3.91 p/Share
|
Jan 05
2021 |
|
OGEN
|
Joseph Hernandez
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 500,000 Reduced 12.43% |
$290,000
$0.58 p/Share
|
Jan 05
2021 |
|
DVCR
|
Osmium Partners, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 114,063 Added 13.25% |
$357,017
$3.13 p/Share
|
Jan 05
2021 |
|
NYC
|
Edward M Weil Jr.
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 4.05% |
$1,251
$8.34 p/Share
|
Jan 05
2021 |
|
GBDC
|
Lawrence E Golub
Chairman |
BUY
Open market or private purchase
|
Indirect | 300 Added 0.01% |
$4,230
$14.1 p/Share
|
Jan 05
2021 |
|
GBDC
|
David Golub
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 300 Added 0.01% |
$4,230
$14.1 p/Share
|
Jan 05
2021 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 44 Added 0.02% |
$34,980
$795.0 p/Share
|
Jan 05
2021 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.26% |
$1,181
$1.75 p/Share
|
Jan 05
2021 |
|
GEF-B
|
Lawrence A. Hilsheimer
EVP and CFO |
BUY
Open market or private purchase
|
Direct | 4,900 Added 5.57% |
$244,314
$49.86 p/Share
|
Jan 05
2021 |
|
PRTY
|
Clifford Sosin
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 316,500 Added 1.94% |
$2,098,395
$6.63 p/Share
|
Jan 05
2021 |
|
AUB
|
Frank Russell Ellett |
BUY
Open market or private purchase
|
Direct | 1,000 Added 7.3% |
$32,820
$32.82 p/Share
|
Jan 05
2021 |
|
GIM
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 301,404 Added 1.41% |
$1,660,736
$5.51 p/Share
|
Jan 05
2021 |
|
FSLF
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 15,005 Added 1.53% |
$208,569
$13.9 p/Share
|
Jan 05
2021 |
|
EFT
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 18,061 Added 0.29% |
$236,960
$13.12 p/Share
|
Jan 05
2021 |